
 
													
 
									 
															 
															Year
 
															DEALS // DEV.
 
															Country
 
															 
															Therapeutic Area
 
															Study Phase
 
															Deal Type
 
															Product Type
 
															Dosage Form
 
															Lead Product
 
															Target

Lead Product(s) : Silicon Dioxide API
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Silicium Laboratories S.L. | San Antonio Technologies S.L. | Catholic University of Murcia (UCAM) | Zaidin Experimental Station, Spanish Council for Scientific Research (CSIC) Agency
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Silica is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 11, 2021
Lead Product(s) : Silicon Dioxide API
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Silicium Laboratories S.L. | San Antonio Technologies S.L. | Catholic University of Murcia (UCAM) | Zaidin Experimental Station, Spanish Council for Scientific Research (CSIC) Agency
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Silicon Dioxide API
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Luxbiotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Neosil on Chronic Effluvium
Details : Neosil Complete (Neosil) is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Alopecia.
Product Name : Neosil Complete
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 06, 2018
Lead Product(s) : Silicon Dioxide API
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Luxbiotech
Deal Size : Inapplicable
Deal Type : Inapplicable

 Reset All
Reset All